An Ongoing Phase 3 Study of Bosutinib (SKI-606) Versus Imatinib In Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

被引：0

作者：

Gambacorti-Passerini, Carlo ^{[1
]}

Kim, Dong-Wook ^{[2
]}

Kantarjian, Hagop M. ^{[3
]}

Brummendorf, Tim H. ^{[4
,5
,11
]}

Dyagil, Irina ^{[6
]}

Griskevicius, Laimonas ^{[7
]}

Malhotra, Hemant ^{[8
]}

Goh, Yeow-Tee ^{[9
]}

Wang, Junyuan ^{[10
]}

Gogat, Karin ^{[10
]}

Cortes, Jorge ^{[3
]}

机构：

[1] Univ Milano Bicocca, Monza, Italy

[2] Seoul St Marys Hosp, Seoul, South Korea

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[5] Univ Klinikum Aachen, Hamburg, Germany

[6] Ukraine Acad Med Sci, Res Ctr Radiat Med, Kiev, Ukraine

[7] Vilnius Univ Hosp, Santarigkio Klin, Vilnius, Lithuania

[8] SMS Med Coll & Hosp, Birla Canc Ctr, Jaipur, Rajasthan, India

[9] Singapore Gen Hosp, Singapore 0316, Singapore

[10] Pfizer Inc, Cambridge, MA USA

[11] Univ Klinikum Aachen, Aachen, Germany

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：95 / 96

页数：2

共 50 条

[1] Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Cortes, Jorge E.
Kantarjian, Hagop M.
Bruemmendorf, Tim H.
Kim, Dong-Wook
Turkina, Anna G.
Shen, Zhi-Xiang
Pasquini, Ricardo
Khoury, H. Jean
Arkin, Steven
Volkert, Angela
Besson, Nadine
Abbas, Richat
Wang, Junyuan
Leip, Eric
Gambacorti-Passerini, Carlo
BLOOD, 2011, 118 (17) : 4567 - 4576
[2] Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia
Gambacorti-Passerini, Carlo
Cortes, Jorge E.
Lipton, Jeff H.
Dmoszynska, Anna
Wong, Raymond S.
Rossiev, Victor
Pavlov, Dmitri
Marchant, Karin Gogat
Duvillie, Ladan
Khattry, Navin
Kantarjian, Hagop M.
Bruemmendorf, Tim H.
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (10) : 947 - 953
[3] Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia
Trask, Peter C.
Cella, David
Besson, Nadine
Kelly, Virginia
Tamas Masszi
Kim, Dong-Wook
LEUKEMIA RESEARCH, 2012, 36 (04) : 438 - 442
[4] Safety and efficacy of bosutinib (SKI-606) in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) following resistance or intolerance to imatinib (IM)
Cortes, J. E.
Kantarjian, H.
Bruemmendorf, T.
Khoury, H. J.
Kim, D.
Turkina, A.
Volkert, A.
Wang, J.
Arkin, S.
Gambacorti-Passerini, C.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[5] SAFETY AND EFFICACY OF SECOND-LINE BOSUTINIB (SKI-606) IN IMATINIB RESISTANT OR INTOLERANT CHRONIC PHASE (CP) CHRONIC MYELOID LEUKEMIA (CML)
Brummendorf, T.
Cortes, J.
Turkina, A.
Masszi, T.
Assouline, S.
Durrant, S.
Volkert, A.
Wang, J.
Arkin, S.
Gambacorti-Passerini, C.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 468 - 468
[6] SAFETY AND MANAGEMENT OF TOXICITIES IN THE PHASE 3 BELA TRIAL OF BOSUTINIB VERSUS IMATINIB IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
Lipton, J.
Kaplan, P.
Dmoszynska, A.
Wong, R.
Rossiev, V.
Pavlov, D.
Duvillie, L.
Gogat, K.
Countouriotis, A.
Khattry, N.
HAEMATOLOGICA, 2012, 97 : 78 - 79
[7] Efficacy and Safety of Bosutinib (SKI-606) in Patients with Chronic Phase (CP) Ph plus Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib
Cortes, Jorge
Kantarjian, Hagop M.
Kim, Dong-Wook
Khoury, H. Jean
Turkina, Anna G.
Shen, Zhi-Xiang
Brummendorf, Tim H.
Chandy, Mammen
Arkin, Steven
Gambacorti-Passerini, Carlo
BLOOD, 2008, 112 (11) : 401 - 401
[8] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Takahashi, Naoto
Matsumura, Itaru
Fujisawa, Shin
Ishizawa, Kenichi
Ono, Takaaki
Sakaida, Emiko
Sekiguchi, Naohiro
Tanetsugu, Yusuke
Fukuhara, Kei
Ohkura, Masayuki
Koide, Yuichiro
Hino, Masayuki
BLOOD, 2019, 134
[9] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
Masayuki Hino
Itaru Matsumura
Shin Fujisawa
Kenichi Ishizawa
Takaaki Ono
Emiko Sakaida
Naohiro Sekiguchi
Yusuke Tanetsugu
Kei Fukuhara
Masayuki Ohkura
Yuichiro Koide
Naoto Takahashi
International Journal of Hematology, 2020, 112 : 24 - 32
[10] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
Hino, Masayuki
Matsumura, Itaru
Fujisawa, Shin
Ishizawa, Kenichi
Ono, Takaaki
Sakaida, Emiko
Sekiguchi, Naohiro
Tanetsugu, Yusuke
Fukuhara, Kei
Ohkura, Masayuki
Koide, Yuichiro
Takahashi, Naoto
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32

← 1 2 3 4 5 →